Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Opioid agonist treatment take-home doses ('carries'): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?
Opioid agonist treatment (OAT) is the primary intervention for opioid use disorder (OUD) in
Canada and the USA. Yet, a number of barriers contribute to sub-optimal treatment uptake …
Canada and the USA. Yet, a number of barriers contribute to sub-optimal treatment uptake …
Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives
SV Aronowitz, E Engel-Rebitzer, A Dolan… - Harm reduction …, 2021 - Springer
Background The majority of individuals with opioid use disorder (OUD) face access barriers
to evidence-based treatment, and the COVID-19 pandemic has exacerbated the United …
to evidence-based treatment, and the COVID-19 pandemic has exacerbated the United …
Assessment of community-level vulnerability and access to medications for opioid use disorder
Importance Given that COVID-19 and recent natural disasters exacerbated the shortage of
medication for opioid use disorder (MOUD) services and were associated with increased …
medication for opioid use disorder (MOUD) services and were associated with increased …
Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior
Drug overdose is the leading cause of accidental death in the US with deaths from opioid
overdose occurring at a higher rate in rural areas. The gaps in the provision of healthcare …
overdose occurring at a higher rate in rural areas. The gaps in the provision of healthcare …
Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth …
A Sivakumar, L Madden, E DiDomizio, A Eller… - International Journal of …, 2022 - Elsevier
Background Healthcare delivery was disrupted during the COVID-19 pandemic, requiring
minimized in-person contact between patients and clinicians. During the pandemic, people …
minimized in-person contact between patients and clinicians. During the pandemic, people …
[HTML][HTML] Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in …
D Aldabergenov, L Reynolds, J Scott… - International Journal of …, 2022 - Elsevier
Background The coronavirus pandemic resulted in many changes which had the potential to
impact mortality related to opioid agonist therapy (OAT; methadone, buprenorphine) …
impact mortality related to opioid agonist therapy (OAT; methadone, buprenorphine) …
[HTML][HTML] The global, regional, and national burden and trends of NAFLD in 204 countries and territories: an analysis from global burden of disease 2019
H Chen, Y Zhan, J Zhang, S Cheng… - JMIR public health …, 2022 - publichealth.jmir.org
Background Nonalcoholic fatty liver disease (NAFLD) poses a substantial socioeconomic
burden and is becoming the fastest growing driver of chronic liver disease, potentially …
burden and is becoming the fastest growing driver of chronic liver disease, potentially …
Changes to methadone maintenance therapy in the United States, Canada, and Australia during the COVID-19 pandemic: A narrative review
Introduction In response to the COVID-19 pandemic, countries across the world made
adaptations to policies regulating the provision of methadone maintenance therapy (MMT) to …
adaptations to policies regulating the provision of methadone maintenance therapy (MMT) to …
The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months
Background Concurrent opioid-related overdose and COVID-19 crises in the US have
imposed unprecedented challenges on people who use illicit opioids. Methods Using the …
imposed unprecedented challenges on people who use illicit opioids. Methods Using the …
[HTML][HTML] Typology of laws restricting access to methadone treatment in the United States: a latent class analysis
Abstract Background In the United States, methadone treatment for opioid use disorder is
only available at opioid treatment programs (OTPs). In addition to federal regulations, states …
only available at opioid treatment programs (OTPs). In addition to federal regulations, states …